Get the Stockscreener App
85.75
0.35%
0.30
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $85.75, with a volume of 879.01K.
It is up +0.35% in the last 24 hours and down -1.49% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$85.45
Open:
$85.36
24h Volume:
879.01K
Relative Volume:
0.54
Market Cap:
$41.61B
Revenue:
$9.93B
Net Income/Loss:
$1.12B
P/E Ratio:
38.11
EPS:
2.25
Net Cash Flow:
$1.58B
1W Performance:
-2.41%
1M Performance:
-1.49%
6M Performance:
-4.25%
1Y Performance:
-7.19%
1-Day Range:
$85.24
$85.87
1-Week Range:
$83.60
$88.01
52-Week Range:
$80.48
$101.10
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Key deals this week: Walt Disney, Harrison Global, Alcon, Steelcase, Joby Aviation and more - Seeking Alpha
STAAR Surgical's largest holder demands books, records on Alcon deal - MSN
Lensar Inc. Q2 Earnings: Revenue Up 10%, Merger with Alcon on Track for End-2025 Close - AInvest
Broadwood Capital Demands Books and Records on STAAR Surgical-Alcon Deal. - AInvest
STAAR Surgical's largest holder demands books, records on Alcon deal (update) (STAA:NASDAQ) - Seeking Alpha
Kepler Capital Maintains Buy Rating on Alcon with CHF86.00 Price Target - AInvest
RxSight (RXST) Q2 Loss Beats Estimates - The Motley Fool
Alcon announces purchase of STARR Surgical for $1.5 billion - MSN
Assessing the STAAR Surgical-Alcon Deal: Is the $28-Per-Share Offer a Bargain or a Missed Opportunity? - AInvest
Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical - Yahoo Finance
Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition By Investing.com - Investing.com Australia
Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition - Investing.com
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
STAAR Surgical Sale to Alcon Raises Concerns Among Investors - AInvest
Market Reverses Gains, Focus on Exxon, Intel, and Alcon - AInvest
Alcon to Acquire STAAR Surgical in $1.5 Billion Deal - The Globe and Mail
Alcon agrees to acquire STAAR Surgical - Ophthalmology Times
Bright move: Alcon offers $1.5B for Staar Surgical - BioWorld MedTech
Alcon to acquire STAAR Surgical - Eyes On Eyecare
STAAR Surgical stock rating downgraded to Neutral by Sidoti on Alcon deal - Investing.com
Alcon to Acquire Staar Surgical for $1.5B - Orange County Business Journal
Alcon agrees to acquire STAAR Surgical for $1.5 billion equity value - MLex
Alcon to acquire STAAR Surgical for about $1.5B - MedTech Dive
STAAR Surgical stock soars after Alcon announces $1.5B acquisition By Investing.com - Investing.com Canada
Why Is STAAR Surgical Stock Skyrocketing Tuesday?Staar Surgical (NASDAQ:STAA), Alcon (NYSE:ALC) - Benzinga
Alcon to Buy STAAR Surgical for $1.5 Billion - Medical Product Outsourcing
Staar Surgical Stock (STAA) Soars on $1.5B Alcon Deal - TipRanks
Staar Surgical Merges with Alcon in $1.5B Deal - TipRanks
First Look: PG&E Surges, Intel Downgraded, and Alcon Acquires ST - GuruFocus
Alcon to Acquire STAAR Surgical for $1.5 Billion - TipRanks
Alcon strikes $1.5bn deal to acquire ailing rival STAAR Surgical - Yahoo Finance
Alcon Buys STAAR Surgical To Expand Eye Care Portfolio - Finimize
Why Did STAAR Surgical Soar 46.02%? Alcon Acquisition - AInvest
Alcon to buy STAAR Surgical for $1.5 billion - breakingthenews.net
Alcon to buy eye health firm STAAR Surgical for $1.5 bln - Investing.com Canada
Alcon Agrees to Acquire STAAR Surgical - Business Wire
Alcon Inc. Sees Relief Buying After Extended DropBuy Alerts With Low Risk Confirmation Noted - metal.it
How does Alcon Inc. generate profit in a changing economyConsistent high-performance stocks - Jammu Links News
What catalysts could drive Alcon Inc. stock higher in 2025Get daily expert analysis on top stocks - Jammu Links News
What markets is Alcon Inc. expanding into Is TECX stock a good long term investment optionGrow your portfolio with growth-oriented stocks - Jammu Links News
What analysts say about Alcon Inc. stockRemarkable growth - Jammu Links News
What institutional investors are buying Alcon Inc. stockAccelerated investment success - Jammu Links News
Is it the right time to buy Alcon Inc. stockSkyrocketing profit margins - Jammu Links News
What drives Alcon Inc. stock priceCapitalize on market momentum for maximum gains - Jammu Links News
What is the dividend policy of Alcon Inc. stockBuild a portfolio that outperforms the market - Jammu Links News
What are the latest earnings results for Alcon Inc.Triple-digit wealth increases - Jammu Links News
What is the risk reward ratio of investing in Alcon Inc. stockUnlock powerful trading signals for profits - Jammu Links News
What are the technical indicators suggesting about Alcon Inc.Invest smarter with daily stock recommendations - Jammu Links News
Stifel Reaffirms Buy on Alcon (ALC), Highlights Eye Care Leader’s Growth Potential - MSN
What markets is PTC Inc. expanding into Is Alcon Inc. stock a good long term investment optionExpert Picks Signals To Watch Now - Jammu Links News
11 Best Medical Stocks to Buy According to Analysts - Insider Monkey
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):